drug

Tirzepatide

MeSH D000098860
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Anders Fink-Jensen, MD, DMSci
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
NCT06939088Phase 2Recruiting

KOLs & investigators

1
Anders Fink-Jensen, MD, DMSc, Professor

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Anders Fink-Jensen, MD, DMSci
company
trial
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
PHASE2
trial
indication
Schizophrenia
indication
Alcohol Abuse/Dependence
indication
Schizophrenia Disorders
indication
Alcohol Use Disorder
indication
KOL
Anders Fink-Jensen, MD, DMSc, Professor
KOL score —
person